Inventiva climbs towards 5 euros, an analyst adjusts the target




By




inventive climbed 2.2% to 4.96 euros on Thursday, while Jefferies is no longer targeting a course of 11.5 euros on the file, against 18 euros previously, while remaining in the purchase. The biopharmaceutical group specializing in the clinical development of small molecules administered orally to…

This stock market news is for subscribers only Privileges


Test our stock market advice for €1, without obligation


I subscribe

Already subscribed? Login

Discover Boursier.com services Privileges

  • 8:30 a.m. recce of the day


    8:30 am
    Recognition of the day

  • 4 to 5 stock tips per day


    4 to 5 tips
    scholarship holders per day

  • weekly newsletter


    Weekly Newsletter “Opportunities”



  • Wallets
    defensive, balanced
    and dynamic


Learn more


©2022 Boursier.com



Source link -87